AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $421,000 | -48.4% | 81,467 | -5.0% | 0.00% | – |
| Q4 2015 | $816,000 | +14.8% | 85,724 | -0.6% | 0.00% | – |
| Q3 2015 | $711,000 | -93.2% | 86,244 | -86.6% | 0.00% | -100.0% |
| Q2 2015 | $10,448,000 | -61.1% | 643,319 | -3.0% | 0.00% | -66.7% |
| Q1 2015 | $26,885,000 | -31.3% | 663,456 | -8.5% | 0.01% | -33.3% |
| Q4 2014 | $39,156,000 | +155.8% | 725,120 | +61.9% | 0.01% | +125.0% |
| Q3 2014 | $15,309,000 | – | 447,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,102,735 | $5,701,000 | 4.95% |
| GREAT POINT PARTNERS LLC | 1,295,416 | $6,697,000 | 2.40% |
| VHCP Management II, LLC | 280,000 | $1,448,000 | 0.95% |
| JW Asset Management, LLC | 189,919 | $982,000 | 0.64% |
| DAFNA Capital Management LLC | 140,600 | $727,000 | 0.63% |
| Wildcat Capital Management, LLC | 235,264 | $1,216,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 154,006 | $796,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 540,632 | $2,795,000 | 0.14% |
| KNOTT DAVID M | 66,000 | $341,220,000 | 0.09% |
| Numeric Investors LLC | 984,309 | $5,089,000 | 0.05% |